Literature DB >> 8603409

Clonal evolution of lung tumors.

G T Chung1, V Sundaresan, P Hasleton, R Rudd, R Taylor, P H Rabbitts.   

Abstract

Lung tumors, particularly squamous cell carcinomas, are believed to develop through a series of morphological abnormalities, driven by underlying somatic genetic changes. One way of studying this process is to analyze candidate somatic genetic changes in samples of squamous metaplasia and bronchial dysplasia of varying degrees of severity as well as tumor from the same patient. This assumes a clonal relationship between these lesions. In this article, we provide evidence that adjacent, physically distinct bronchial abnormalities are clonally related. This has been achieved using a plaque assay technique to detect the same p53 mutation, present throughout a tumor specimen, in a small proportion of cells in an adjacent squamous metaplasia. In addition, we have obtained two dysplasia samples from a tumor-free patient over a 9-month interval. The earlier sample had one p53 mutation, whereas the later sample has to p53 mutations on different alleles. Thus, the pattern of clonal evolution detected in the parallel samples mimics the pattern seen in longitudinal samples and supports the analysis of synchronously collected samples for the study of tumor progression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8603409

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis.

Authors:  W A Franklin; A F Gazdar; J Haney; I I Wistuba; F G La Rosa; T Kennedy; D M Ritchey; Y E Miller
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

3.  Molecular damage in the bronchial epithelium of current and former smokers.

Authors:  I I Wistuba; S Lam; C Behrens; A K Virmani; K M Fong; J LeRiche; J M Samet; S Srivastava; J D Minna; A F Gazdar
Journal:  J Natl Cancer Inst       Date:  1997-09-17       Impact factor: 13.506

Review 4.  Genetics and pulmonary medicine. 7. Somatic mutations in the development of lung cancer.

Authors:  M Roland; R M Rudd
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

5.  Topographical distributions of allelic loss in individual non-small-cell lung cancers.

Authors:  Y Yatabe; H Konishi; T Mitsudomi; S Nakamura; T Takahashi
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

6.  Field cancerization in the intestinal epithelium of patients with Crohn's ileocolitis.

Authors:  Susan Galandiuk; Manuel Rodriguez-Justo; Rosemary Jeffery; Anna M Nicholson; Yong Cheng; Dahmane Oukrif; George Elia; Simon J Leedham; Stuart A C McDonald; Nicholas A Wright; Trevor A Graham
Journal:  Gastroenterology       Date:  2011-12-13       Impact factor: 22.682

Review 7.  Multifocal epithelial tumors and field cancerization: stroma as a primary determinant.

Authors:  G Paolo Dotto
Journal:  J Clin Invest       Date:  2014-04-01       Impact factor: 14.808

8.  Genomic evidence of pre-invasive clonal expansion, dispersal and progression in bronchial dysplasia.

Authors:  Frank McCaughan; Christodoulos P Pipinikas; Sam M Janes; P Jeremy George; Pamela H Rabbitts; Paul H Dear
Journal:  J Pathol       Date:  2011-04-19       Impact factor: 7.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.